|
⚲
|
| Keyboard |
| AN2 Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001880438 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001880438] | |
| 10-Q | [0001880438] | |
| 3 | [0001880438] | |
| 4 | [0001880438] | |
| 8-K | [0001880438] | |
| D | [0001880438] | |
| SC 13D | [0001880438] | |
| SC 13G | [0001880438] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| AN2 Therapeutics Inc | |
| Williams Sarah Joanne | |
| Aziz Kabeer | |
| Marks Gilbert Lynn | |
| Martin Patricia A | |
| Spigelman Melvin K | |
| Easom Eric | |
| Readnour Robin Shane | |
| Day Lucy | |
| Chanda Sanjay | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 50,150 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 23,742 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 10,362 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 10,362 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 16,941 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 23,742 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 249,999 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 267,650 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 249,999 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 225,000 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 225,000 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 267,650 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 23,742 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 20,724 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 20,724 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 23,742 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 16,941 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 82,300 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Disposed to issuer | 66,000 | ||
|
AN2 Therapeutics Inc ANTX
Stock Option (right to buy) · derivative
|
2026-03-19 | Grant | 66,000 | ||
| showing 20 of 200 most recent transactions | |||||